CBS 2019
CBSMD教育中心
中 文

Other Relevant Articles

Abstract

Recommended Article

Management of No-Reflow Phenomenon in the Catheterization Laboratory Advances in Coronary No-Reflow Phenomenon-a Contemporary Review Residual Inflammatory Risk in Patients With Low LDL Cholesterol Levels Undergoing Percutaneous Coronary Intervention Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association Major trials in coronary intervention from 2018 ACC/AATS/AHA/ASE/ASNC/HRS/SCAI/SCCT/SCMR/STS 2019 Appropriate Use Criteria for Multimodality Imaging in the Assessment of Cardiac Structure and Function in Nonvalvular Heart Disease: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and the Society of Thoracic Surgeons Cholesterol-Lowering Agents Mode of Death in Heart Failure With Preserved Ejection Fraction

Review ArticleVolume 10, Issue 3, February 2017

JOURNAL:JACC: Cardiovascular Interventions Article Link

Management of No-Reflow Phenomenon in the Catheterization Laboratory

Rezkalla SH, Stankowski RV, Hanna J et al. Keywords: ST-segment elevation myocardial infarction; no-reflow; percutaneous coronary intervention

FULL TEXT PDF